THYROID-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2023-01-31 lwfighting 来自广东省

投稿要90刀，慎重

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2022-08-05 ATGC

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：儿童甲状腺癌
经验分享：27-Apr-2022 SUBMITTED
27-May-2022 Major Revision
Accept (04-Aug-2022)

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2022-12-20 986893294 来自广东省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2022-03-21 tengyuzhu123

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧

231 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2022-05-01 ms8000000941964640

投出去以后的状态都有哪些？会显示已送外审、外审结束吗？

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2021-12-27 Mia

期刊给我发了一封信，但我看不懂怎么办？

162 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2021-12-27 MS68862005

期刊的审稿时间一般是多久？

285 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2021-05-28 ms2000000877004154

审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0
偏重的研究方向：流行病学;生态学研究;甲状腺癌
经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。

332 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2020-02-15 南瓜。

请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢

469 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2112403, encodeId=c51c2112403a1, content=投稿要90刀，慎重, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIro8BKyich3jPqp62gic5R8hkONbSspGYicTDB8X8tGBPDBAS7N4xrWtYtShdnpdUXFKXg5ibSUUIBicw/132, createdBy=75812303304, createdName=lwfighting, createdTime=Tue Jan 31 16:23:11 CST 2023, time=2023-01-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1236777, encodeId=36c61236e77ce, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：儿童甲状腺癌 经验分享：27-Apr-2022 SUBMITTED 27-May-2022 Major Revision Accept (04-Aug-2022), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cf11618605, createdName=ATGC, createdTime=Fri Aug 05 15:27:55 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106772, encodeId=15402106e720f, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投的甲状腺相关眼病方向论文，审了快三个月。想较于给出的意见，审稿速度可谓非常慢了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75f72876957, createdName=986893294, createdTime=Tue Dec 20 09:08:07 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204781, encodeId=d6251204e8100, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿两月后收到返修信，要求一个月内返回，建议非常多，时间很紧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09503031561, createdName=tengyuzhu123, createdTime=Mon Mar 21 23:16:54 CST 2022, time=2022-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216043, encodeId=00711216043c7, content=投出去以后的状态都有哪些？会显示已送外审、外审结束吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fab08143999, createdName=ms8000000941964640, createdTime=Sun May 01 12:57:12 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098860, encodeId=b67410988606b, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1098859, encodeId=dcef109885928, content=期刊的审稿时间一般是多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969169, encodeId=8a619691698f, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:90.0 偏重的研究方向：流行病学;生态学研究;甲状腺癌 经验分享：2021.04.30投出，05.27被拒。两个审稿人，建议温和且详细，试投还是很值得的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=020e5490402, createdName=ms2000000877004154, createdTime=Fri May 28 12:03:07 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584763, encodeId=ee9d584e6342, content=请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=469, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/08/f64a53ffbc1ea1e28c117352202f7d06.jpg, createdBy=22535224385, createdName=南瓜。, createdTime=Sat Feb 15 00:00:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=462, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=)]

2020-04-10 Jerry6746

你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表:
又投寄了一篇，希望下半年发表出来

117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来

462 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务